<DOC>
	<DOC>NCT00506610</DOC>
	<brief_summary>The purpose of this study is to determine whether T-62 is effective in providing relief of pain that can occur after an individual experiences a shingles outbreak, which is an infection in adults caused by the same virus that causes chicken pox.</brief_summary>
	<brief_title>A Study to Determine if an Investigational Pain Medicine Provides Relief of Chronic Pain After a Shingles Outbreak</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia, Postherpetic</mesh_term>
	<criteria>Has a clinical diagnosis of Postherpetic Neuralgia (PHN) Experiencing pain for at least 3 months after the healing of shingles rash Has at least a weekly average pain intensity of equal to or greater than 4 out of 10 Females must not be pregnant or breastfeeding and practicing an acceptable method of birth control, or be surgically sterile or postmenopausal Will not consume grapefruit or grapefruit juice during the study Has a current acute or unstable chronic disease other than Postherpetic Neuralgia (PHN) Has clinically important medical disorder Uses certain types of medications for heart conditions Unwilling/unable to discontinue use of medications for treatment of neuropathic pain Has a history of hypersensitivity to any medication or soy product Has liver or kidney disease Has asthma that required treatment within the last year Has HIV or hepatitis (other than hepatitis A) Has a history of alcohol abuse within the past 2 years Has a history of (within last 2 years) or currently abuses prescription or illegal drugs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Pain</keyword>
	<keyword>Postherpetic Neuralgia</keyword>
	<keyword>Neuralgia, Postherpetic</keyword>
	<keyword>Shingles</keyword>
	<keyword>Herpes Zoster</keyword>
	<keyword>Neuropathic Pain</keyword>
</DOC>